Pten suppresses breast cancer cell growth by phosphatase activity- dependent arrest followed by cell death

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5808-5814

  Weng, Liang Ping ^a   Smith, Wendy M ^a   Dahia, Patricia L M ^a,b   Ziebold, Ulrike ^c   Gil, Elad ^c   Lees, Jacqueline A ^c   Eng, Charis ^a,d,e  

^a OHIO STATE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE; PROTEIN PHOSPHATASE PTEN; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CELL DEATH; CELL STRAIN MCF 7; GENE MUTATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; BREAST NEOPLASMS; CELL DEATH; CELL DIVISION; ENZYME INHIBITORS; FEMALE; G1 PHASE; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASM PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033571477     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittman, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
2. Li, D-M., and Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor B. Cancer Res., 57: 2124-2129, 1997.
3. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997
4. Eng, C., and Parsons, R. Cowden syndrome. In: B. Vogelstein and K. W. Kinzler (eds.), The Genetic Basis of Human Cancer, pp. 519-526. New York: McGraw-Hill, 1998.
5. Eng, C. Genetics of Cowden syndrome: through the looking glass of oncology. Int. J. Oncol., 12: 701-710, 1998.
6. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C., and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.
7. Marsh, D. J., Dahia, P. L. M., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., and Eng, C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.
8. Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Rulland, J., Penninger, J. M., Siderovski, D. P., and Mak, T. W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95: 1-20, 1998.
9. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nat. Genet., 19: 348-355, 1998.
10. Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., del Barco Barrantes, I., Ho, A., Wakeham, A., Itie, A., Khoo, W., Fukumoto, M., and Mak, T. W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol., 8: 1169-1178, 1998.
11. Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., and Parsons, R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA, 96: 1563-1568, 1999.
12. Maehama, T., and Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger phosphoinositol 3,4,5-triphosphate. J. Biol. Chem., 273: 13375-13378, 1998.
13. Tamura, M., Gu, J., Matsumoto, K., Aota, S-i., Parsons, R., and Yamada, K. M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science (Washington DC), 280: 1614-1617, 1998.
14. Li, D. M., and Sun, H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. USA, 95: 15406-15411, 1998.
15. Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M. P., Tonks, N., and Parsons, R. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res., 58: 5667-5672, 1998.
16. Furnari, F. B., SuHuang, H-J., and Cavanee, W. K. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res., 58: 5002-5008, 1998.
17. Cheney, I. W., Johnson, D. E., Vaillancourt, M-T., Avanzini, J., Morimoto, A., Demers, G. W., Wills, K. N., Shabram, P. W., Bolen, J. B., Tavtigian, S. V., and Bookstein, R. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res., 58: 2331-2334, 1998.
18. Myers, M. P., Pass, I., Batty, I. H., van der Kaay, J., Storalov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., and Tonks, N. K. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA, 95: 13513-13518, 1998.
19. Leonard, C. J., Canman, C. E., and Kastan, M. B. The role of p53 in cell-cycle control and apoptosis. Important Adv. Oncol., 33-42, 1995.
20. Evan, G. I., Brown, L., Whyte, M., and Harrington, E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol., 7: 825-834, 1995.
21. Bonneton, C., Larue, L., and Thiery, J. P. Current data on the role of the APC protein in the origin of colorectal cancer. Bull. Cancer (Phila.), 84: 1053-1060, 1997.
22. Morin, P. J., Vogelstein, B., and Kinzler, K. W. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA, 93: 7950-7954, 1996.
23. Marsh, D. J., Dahia, P. L. M., Coulon, V., Zheng, Z., Dorion-Bonnet, F., Call, K. M., Little, R., Lin, A. Y., Eeles, R. A., Goldstein, A. M., Hodgson, S. V., Richardson, A-L., Robinson, B. G., Weber, H. C., Longy, M., and Eng, C. Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer, 21: 61-69, 1998.
24. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
25. Weng, L. P., Yuan, J., and Yu, Q. Overexpression of the transmembrane tyrosine phosphatase LAR activates the caspase pathway and induces apoptosis. Curr. Biol., 8: 247-256, 1998.
26. Perren, A., Weng, L. P., Boag, A. H., Ziebold, U., Thakore, K., Dahia, P. L. M., Komminoth, P., Less, J. A., Mulligan, L. M., Mutter, G. L., and Eng, C. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am. J. Pathol., 155: 1253-1260, 1999.
27. Dahia, P. L. M., Aguiar, R. C. T., Alberta, J., Kum, J., Caron, S., Sills, H., Marsh, D. J. M., Freedman, A., Ritz, J., Stiles, C., and Eng, C. PTEN is inversely correlated with the cell survival factor PKB/Akt and is inactivated by diverse mechanisms in haematologic malignancies. Hum. Mol. Genet., 8: 185-193, 1999.
28. Gossen, M., Bonin, A. L., Freundlieb, S., and Bujard, H. Inducible gene expression systems for higher eukaryotic cells. Curr. Opin. Biotechnol., 5: 516-520, 1994.
29. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H. Transcriptional activation by tetracyclines in mammalian cells. Science (Washington DC), 268: 1756-1769, 1995.
30. Marsh, D. J., Coulon, V., Lunetta, K. L., Rocca-Serra, P., Dahia, P. L. M., Zheng, Z., Liaw, D., Caron, S., Duboué, B., Lin, A. Y., Richardson, A-L., Bonnetblanc, J-M., Bressieux, J-M., Cabarrot-Moreau, A., Chompret, A., Demange, L., Eeles, R. A., Yahanda, A. M., Fearon, E. R., Fricker, J-P., Gorlin, R. J., Hodgson, S. V., Huson, S., Lacombe, D., LePrat, F., Odent, S., Toulouse, C., Olopade, O. I., Sobol, H., Tishler, S., Woods, C. G., Robinson, B. G., Weber, H. C., Parsons, R., Peacocke, M., Longy, M., and Eng, C. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet., 7: 507-515, 1998.
31. Carpenter, C. L., and Cantley, L. C. Phosphoinositide kinases. Curr. Opin. Cell Biol., 8: 153-158, 1996.
32. Downward, J. Ras signalling and apoptosis. Curr. Opin. Genet. Dev., 8: 49-54, 1998.
33. Cheney, I. W., Neuteboom, S. T. C., Vaillancourt, M-T., Ramachandra, M., and Bookstein, R. Adenovirus-mediated gene entry of MMAC1/PTEN to glioblastoma inhibits S phase entry by the recruitment of p27Kip2 and cyclin E/CDK2 complexes. Cancer Res., 59: 2318-2323, 1999.
34. Davies, M. A., Lu, Y., Sano, T., Fang, X., Tang, P., LaPuschin, R., Koul, D., Bookstein, R., Stokoe, D., Yung, W. K. A., Mills, G. B., and Steck, P. A. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res., 58: 5285-5290, 1998.
35. Data, K., Franke, T. F., Chan, T. O., Makris, A., Yang, S. I., Kaplan, D. R., Morrison, D. K., Golemis, E. A., and Tsichlis, P. AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation. Mol. Cell. Biol., 15: 2304-2310, 1995.
36. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenburg, M. R. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (Washington DC), 275: 661-665, 1997.
37. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P., and Hay, N. The PI-3 kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11: 701-713, 1997.
38. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997.
39. Yao, R., and Cooper, G. M. Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science (Washington DC), 267: 2003-2006, 1995.
40. Fumari, F. B., Lin, H., Huang, H-J. S., and Cavanee, W. K. Growth suppression of glioma cells by PTEN requires a functional catalytic domain. Proc. Natl. Acad. Sci. USA, 94: 12479-12484, 1997.
41. Robertson, G. P., Furnari, F. B., Miele, M. E., Glendening, M. J., Welch, D. R., Fountain, J. W., Lugo, T. G., Huang, H. J., and Cavanee, W. K. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proc. Natl. Acad. Sci. USA, 95: 9418-9423, 1998.
42. Takuwa, N., Fukui, Y., and Takuwawa, Y. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p17(S6K)-independent signaling in growth factor stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol., 19: 1346-1358, 1999.
43. Dufourny, B., Ablas, J., van Teeffelen, H. A., van Schaik, F. M., van den Burg, B., Steenbergh, P. H., and Sussenbach, J. S. Mitogenic signaling of insulin-like growth factor I in human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem., 272: 31163-31171, 1997.
44. Bacqueville, D., Casagrande, F., Perret, B., Chap, H., Darbon, J. M., and Breton-Douillon, M. Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1. Biochem. Biophys. Res. Commun., 244: 630-636, 1998.
45. Kanda, S., Hodgkin, M. N., Woodfield, R. J., Wkelam, M. J., Thomas, G., and Claesson-Welsh, L. Phosphatidylinositol 3 kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J. Biol. Chem., 272: 23347-23353, 1997.
46. Lane, H. A., Fernandez, A., Lamb, N. J., and Thomas, G. p70sk6 function is essential for G1 progression. Nature (Lond.), 363: 170-172, 1993.
47. Ahmed, N. N., Grimes, H. L., Bellacosa, A., Chan, T. O., and Tsichlis, P. N. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA, 94: 3627-3632, 1997.
48. Brunei, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell, 98: 857-868, 1999.
49. Hungerford, J. E., Compton, M. T., Matter, M. L., Hoffstrom, B. G., and Otey, C. A. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J. Cell Biol., 135: 1383-1390, 1996.
50. Paterson, J. W. BRCA1: a review of structure and putative function. Dis. Markers, 13: 261-274, 1998.
51. Shao, N., Chai, Y. L., Shyam, E., Reddy, P., and Rao, V. N. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene, 13: 1-7, 1996.